Shaimaa Hamza

7PUBLICATIONS
7CO-AUTHORS
Molecular targetsInnate immunityPredictive and prognostic markersVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2024
Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.

Shaimaa Hamza, Ekaterina E Garanina, Layaly Shkair

|Jun 28, 2023
Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia.

Shaimaa Hamza, Ekaterina Martynova, Ekaterina Garanina

|Mar 11, 2023
Blocking the Hormone Receptors Modulates NLRP3 in LPS-Primed Breast Cancer Cells.

Shaimaa Hamza, Ekaterina E Garanina, Mohammad Alsaadi

|Aug 26, 2022
Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.

Gulcin Tezcan, Mohammad Alsaadi, Shaimaa Hamza

|Oct 23, 2021
Long Term Immune Response Produced by the SputnikV Vaccine.

Ekaterina Martynova, Shaimaa Hamza, Ekaterina E Garanina

|Sep 28, 2021
Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation.

Mohammad Alsaadi, Gulcin Tezcan, Ekaterina E Garanina

Pageof 2